Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with alpha-interferon against herpes simplex virus type 2 in mice
- PMID: 6335382
- PMCID: PMC180056
- DOI: 10.1128/AAC.26.6.937
Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with alpha-interferon against herpes simplex virus type 2 in mice
Abstract
The acyclic nucleoside DHPG [9-(1,3-dihydroxy-2-propoxymethyl)guanine] and recombinant human alpha-interferon of clones A/D potentiate each other's antiviral activity against a systemic infection with herpes simplex virus type 2. The effective dose at which 50% of the mice survived was lowered approximately 10-fold for DHPG when it was given in combination with a marginally effective dose of alpha-interferon and greater than 10-fold for alpha-interferon when it was given in combination with a nontherapeutic dose of DHPG.
Similar articles
-
Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with beta-interferon against herpes simplex virus type 2 in mice.Antimicrob Agents Chemother. 1984 May;25(5):563-5. doi: 10.1128/AAC.25.5.563. Antimicrob Agents Chemother. 1984. PMID: 6610387 Free PMC article.
-
Enhanced efficacy of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine in combination with gamma interferon against herpes simplex virus type 2 in mice.Antiviral Res. 1985 Jun;5(3):137-44. doi: 10.1016/0166-3542(85)90046-4. Antiviral Res. 1985. PMID: 2992368
-
Potent synergistic inhibition of herpes simplex virus-2 by 9-[(1, 3-dihydroxy-2-propoxy)methyl]guanine in combination with recombinant interferons.Biochem Biophys Res Commun. 1984 Apr 16;120(1):66-73. doi: 10.1016/0006-291x(84)91414-1. Biochem Biophys Res Commun. 1984. PMID: 6201172
-
Promising new antiviral drugs.J Am Acad Dermatol. 1988 Jan;18(1 Pt 2):212-8. doi: 10.1016/s0190-9622(88)70031-6. J Am Acad Dermatol. 1988. PMID: 2448352 Review.
-
Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy.Clin Microbiol Rev. 2003 Jan;16(1):114-28. doi: 10.1128/CMR.16.1.114-128.2003. Clin Microbiol Rev. 2003. PMID: 12525428 Free PMC article. Review.
Cited by
-
Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections.Drugs. 1990 Apr;39(4):597-638. doi: 10.2165/00003495-199039040-00008. Drugs. 1990. PMID: 2161731 Review.
-
Synergistic activity of combinations of recombinant human alpha interferon and acyclovir, administered concomitantly and in sequence, against a lethal herpes simplex virus type 1 infection in mice.Antimicrob Agents Chemother. 1985 Jul;28(1):1-4. doi: 10.1128/AAC.28.1.1. Antimicrob Agents Chemother. 1985. PMID: 4037769 Free PMC article.
-
Acyclonucleosides: Part 2. diseco-Nucleosides.Adv Heterocycl Chem. 1997;68:1-88. doi: 10.1016/S0065-2725(08)60360-8. Epub 2008 Feb 28. Adv Heterocycl Chem. 1997. PMID: 32287460 Free PMC article.
-
Xylotubercidin against herpes simplex virus type 2 in mice.Antimicrob Agents Chemother. 1986 Nov;30(5):719-24. doi: 10.1128/AAC.30.5.719. Antimicrob Agents Chemother. 1986. PMID: 3800347 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical